title: The treatment of adolescents and young adults with acute lymphoblastic leukemia.
abstract: Adolescents and young adult (AYA) patients with acute lymphoblastic leukemia (ALL), 16-40 years of age, were historically not the focus of prospective studies on ALL treatment. This population has unique genetic, immunophenotypic, and clinical features, differing from both pediatric and older adult patients, with outcomes somewhere between these two populations. However, it has been suggested that outcomes (event-free and overall survival) for these patients are better when they are treated with pediatric-inspired therapeutic regimens. This has been attributed to increased dose and frequency of non-myelosuppressive therapy, earlier and more frequent central nervous system prophylaxis, and longer maintenance therapy. However, management by the treating oncologist and adherence by the patients are equally vital. Ultimately, the combination of improved treatment regimens and organizational management are required to improve outcomes of ALL in the AYA population.
authors.affiliation: Department of Hematologic Oncology and Blood Disorders, Cleveland Clinic, Taussig Cancer Institute, 9500 Euclid Avenue, Cleveland, OH 44195, USA.
authors.forename: Joshua
authors.initials: J
authors.lastname: Lukenbill
authors.forename: Anjali S
authors.initials: AS
authors.lastname: Advani
mesh_terms: D000293:Adolescent; D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D008297:Male; D055118:Medication Adherence; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy*; D055815:Young Adult
references.citation: Science. 2004 Oct 8;306(5694):269-71
references.pmid: 15472075
references.citation: J Clin Oncol. 2009 Feb 20;27(6):911-8
references.pmid: 19124805
references.citation: J Clin Oncol. 2003 Mar 1;21(5):774-80
references.pmid: 12610173
references.citation: J Clin Oncol. 2011 Feb 1;29(4):386-91
references.pmid: 21172890
references.citation: Blood. 2004 Oct 15;104(8):2492-8
references.pmid: 15198948
references.citation: Blood. 2006 Feb 1;107(3):1116-23
references.pmid: 16195338
references.citation: Blood. 1995 Apr 15;85(8):2025-37
references.pmid: 7718875
references.citation: Blood. 1986 Jul;68(1):1-31
references.pmid: 2941082
references.citation: J Clin Oncol. 2007 Mar 1;25(7):813-9
references.pmid: 17327603
references.citation: Blood. 2008 Feb 15;111(4):1827-33
references.pmid: 18048644
references.citation: Blood. 1987 Nov;70(5):1584-8
references.pmid: 3311207
references.citation: Blood. 2007 Apr 15;109(8):3189-97
references.pmid: 17170120
references.citation: J Clin Oncol. 2009 Nov 1;27(31):5175-81
references.pmid: 19805687
references.citation: Blood. 2000 Jun 1;95(11):3310-22
references.pmid: 10828010
references.citation: Lancet Oncol. 2010 May;11(5):429-38
references.pmid: 20409752
references.citation: Leukemia. 2006 Dec;20(12):2155-61
references.pmid: 17039234
references.citation: Cancer. 2011 Jan 15;117(2):238-49
references.pmid: 20824725
references.citation: Crit Rev Oncol Hematol. 2004 Jun;50(3):223-61
references.pmid: 15182827
references.citation: Cancer Cell. 2012 Aug 14;22(2):153-66
references.pmid: 22897847
references.citation: Blood. 1988 Jan;71(1):123-31
references.pmid: 3422030
references.citation: Haematologica. 2008 Aug;93(8):1161-8
references.pmid: 18556413
references.citation: Blood. 2010 Jan 14;115(2):206-14
references.pmid: 19897583
references.citation: Cancer. 2004 Oct 1;101(7):1677-84
references.pmid: 15378506
references.citation: Cancer. 2011 Apr 15;117(8):1583-94
references.pmid: 21472706
references.citation: Hematology Am Soc Hematol Educ Program. 2005;:123-30
references.pmid: 16304369
references.citation: Blood. 2005 Dec 1;106(12):3760-7
references.pmid: 16105981
references.citation: Blood. 1999 Jun 1;93(11):3983-93
references.pmid: 10339508
references.citation: Cancer Cell. 2002 Feb;1(1):75-87
references.pmid: 12086890
references.citation: Blood. 2012 Jan 5;119(1):34-43
references.pmid: 22086414
references.citation: Leuk Res. 2011 Oct;35(10):1312-20
references.pmid: 21596436
references.citation: Blood. 2008 Sep 1;112(5):1646-54
references.pmid: 18502832
references.citation: J Clin Oncol. 2009 Nov 1;27(31):5189-94
references.pmid: 19805689
references.citation: J Clin Oncol. 2000 Feb;18(3):547-61
references.pmid: 10653870
references.citation: Blood. 2001 Mar 1;97(5):1211-8
references.pmid: 11222362
references.citation: J Clin Oncol. 2007 Nov 1;25(31):4914-21
references.pmid: 17971588